Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Maastricht Psychedelic Symposium
On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).
Click below to watch the entire symposium
Read about our new paper on the neurological origins of a visual psychedelic hallucination
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Sarah Roche, MSc
Psilocybin, Sustainability, Environment
My PhD research focuses on psychedelic drugs as a tool to investigate the cognitive mechanisms underlying changes in sustainable behavior.
Dr. Natasha Mason
Psychedelics, Neuroadaptations, Plasticity
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
Dr. Peter van Ruitenbeek
My name is Dr. Peter van Ruitenbeek and I work as an assistant professor. That means I teach and do research at the faculty of psychology and neuroscience.
Dr. C. Rob Markus
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Janine Kox, MSc
Stress Resilience, Psychedelics, Cognitive biases
My research focuses on the effects of stress, sleep deprivation, on cognitive biases, by using the transdiagnostic rDOC approach, and see whether psychedelics such as LSD, Psilocybin and even non-hallucinogenic psychedelics can reverse these effects.
Iva Totomanova, MSc
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
Prof. Jan Ramaekers
I work as a professor in psychopharmacology at Maastricht University in the Netherlands. My research combines methods from psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug induced changes in human performance.
Katharina Lege, MSc
Cannabinoids, Neuroimaging, Consciousness
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
Dr. Lilian Kloft
Cognition, Drugs, False Memory
I am a postdoctoral researcher in the fields of psychopharmacology and forensic psychology with an international education from various high-class universities.
Psychedelic Research
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
Ayahuasca, creativity, divergent thinking, convergent thinking
→
Ritualistic use of ayahuasca enhances a shared functional connectome identity with others
Functional Connectivity, Ayahuasca, Ritual
→
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach
→
Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
Psychedelics, vision, retinofugal, tripping, hallucinations, visual
→
Cannabis Research
Cognition and motor control as a function of 9-THC concentration in serum and oral fluid: Limits of impairment
→
Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint
→
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Cannabis, Glutamate, Functional Connectivity
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.